Samples were analysed using a method previously described and validated by Le Maux, 148
Nongonierma, and FitzGerald (2015), with some modifications. Briefly, HILIC-UPLC was 149 performed on an Acquity BEH Amide column (2.1 × 150 mm, 1.7 μm, 130 Å) equipped with 150 an Acquity BEH Amide 1.7 μm vanguard pre-column, both from Waters. A linear gradient 151 from 97 to 65% (v/v) MeCN, containing 0.1% (v/v) TFA, was applied for 60 min at a flow 152 rate of 0.2 mL min -1 . Samples (25 µg) were injected onto the column. The column 153 temperature was maintained at 40ºC. MS measurements were performed over a 100-2200 m/z 154 acquisition range. 155 MS data were processed on PEAKS 7.5 (Bioinformatics Solutions Inc., Waterloo, Ontario, 156 Canada). Peptides were identified using an in-house milk protein database composed of the 157 main bovine milk proteins (βlg, αla, BSA, lactoferrin, α s1 -, α s2 -, β-and κ-casein) as given in 158 Uniprot (http://www.uniprot.org/uniprot/). The database search used was specified as 159 follows: data were refined using error tolerances of 15 ppm and 0.5 Da for precursor mass 160 and fragment ion, respectively. A non-specific enzyme cleavage was selected, oxidation of 161
Met and phosphorylation of Ser, Thr and Tyr were set as variable modifications. The results 162 were filtered using the following parameters: a 50% de novo threshold (average local 163 confidence score, ALC) and a 0.1% false discovery rate (FDR). Only de novo peptides that 164 fully matched bovine milk protein sequences were considered valid for peptide identification. 165
The data from hydrolysate triplicates were pooled and considered as one sample by PEAKS. 166
Comparison of samples having the same DH but different E:S was achieved with PEAKS 167 using the "comparison PEAKS results" function. Visualisation of the common peptides 168 released in samples having similar DH but different E:S was then carried out with Venn 169 diagrams using the venn function (Version 1.7) on Matlab (MathWorks Inc.). Only the 170 peptides present in βlg variant A were visualised on Venn diagrams.
DPP-IV inhibition assay 172
The hydrolysates were dispersed in MS-grade water, at final concentrations ranging from 3.1 173 × 10 -2 to 3.1 mg protein equivalent mL -1 . The positive control, diprotin A, was assessed at 174 final concentrations ranging from 12.5 × 10 -2 and 12.5 µg mL -1 . The DPP-IV inhibition assay 175 was carried out as described previously (Nongonierma & FitzGerald, 2013a) . Briefly, 25 µL 176 sample was pipetted in a 96-well clear microplate (Sarstedt, Dublin, Ireland) and mixed with 177 the reaction substrate, Gly-Pro-pNA (final concentration 0.200 mM). DPP-IV (final 178 concentration 0.0025 units mL -1 ) was subsequently added to initiate the reaction. The 179 negative control consisted of 100 mM Tris-HCl buffer pH 8.0 and Gly-Pro-pNA. The 180 microplate was incubated at 37ºC for 60 min in a microplate reader (Biotek Synergy HT). 181
The pNA released was measured by monitoring the absorbance at 405 nm. The DPP-IV half 182 maximal inhibitory concentration (IC 50 ) values were determined by plotting the percentage 183 inhibition as a function of the concentration of test compound. Each sample was analysed in 184 triplicate (n=3). 185
Statistical analysis 186
Results were compared by a one way ANOVA with a Tukey's test at a significance level of p 187 < 0.05, using R software 3.1.0 (R Foundation for Statistical Computing, Vienna, Austria) and 188 the Rcmdr library version 2.1-7 package. 189 3 Results and discussion (Table 1) . 202
The molecular mass distribution profiles of the βlgH samples are presented in Fig. 1 . 203
Hydrolysis was demonstrated by the breakdown of the high molecular mass components (> 204 10 kDa) within all the βlgH samples as compared to the βlg-control. All the DH9 samples had 205 similar molecular mass distributions (p > 0.05). Likewise, all the DH13 samples had similar 206 molecular mass distributions (p > 0.05). As expected, the DH13 samples had a significantly 207 lower proportion of large compounds (> 10 kDa) and higher proportion of compounds < 1 208 kDa compared to all the DH9 samples (p < 0.05). 209
The E:S employed is a factor known to impact on reaction kinetics (Whitehurst & Law, 210 2002) . In this study, the duration of the hydrolysis reaction required to reach the same DH 211 was inversely proportional to the E:S as expected. For instance, a βlgH generated with an E:S 212 of 0.5% needed approximately twice as much time to reach the same DH compared to a βlgH 213 generated with an E:S of 1% (Table 1) . This is in agreement with the effect of enzyme 214 concentration, as described in the literature, when there are no artefacts present in the system, 215
i.e., enzyme activators or inhibitors. For instance, Dixon and Webb (1979) stated that for a 216
given period of time, two enzyme molecules, that act independently, metabolise twice as 217 much substrate as one enzyme molecule provided the substrate is in excess. 218
Peptide identification in βlgH samples by HILIC-UPLC-MS/MS 219
The peptides within βlgHs were sequenced using HILIC-UPLC-MS/MS. The protein 220 coverage for βlg variant A was established by the observation of the peptide signals by 221 HILIC-MS/MS, using the protein database and without considering the de novo sequencing. 222
Ninety-eight to hundred per cent of the protein coverage was achieved using these digestion 223
conditions. The number of peptides identified for βlg variant A ranged from 125 to 169, for 224 βlgH-0.5-DH13 and βlgH-1-DH9, respectively (Supplementary Tables S1 and S2 ). Mostly 225 Lys (> 20%), Leu (> 12.0%), Val (> 8.3%), Glu (> 6.5%), Ile (> 5.7%) and Ala (> 4.6%) 226 residues were found at the C-terminal sequence of peptides released from βlg by elastase both 227 at DH 9 and 13% (Fig. 2) . 228
The number of peptides identified, being common or specific to each sample, were presented 229 using Venn diagrams for each DH value ( Fig. 3A and 3B ). These show that 62 and 84% of 230 the peptides were common for the βlgH samples hydrolysed with the three different E:S, for 9 231 and 13% DH, respectively. The DH9 samples generated at different E:S shared 109 common 232 peptides (Fig. 3A) whereas the DH13 samples shared 105 common peptides (Fig. 3B) . 233
Samples generated using the same E:S but different DH values had several peptide sequences 234 in common. For instance, 104, 120 and 106 common peptides were present for samples with 235 E:S values of 0.5, 1.0 and 1.5%, respectively (data not shown). 236
Several of the peptides released from βlg by elastase had Ala, Ile, Leu, Val, Ser, Tyr and Thr 237 residues at their C-terminus (Fig. 2) . This is in agreement with the cleavage specificity of 238 pancreatic elastase (Godfrey, 1996) . However, numerous peptides having a Lys or Glu C-239 terminus were also identified within the βlgHs (Fig. 2) . C-terminal Lys residues may be 240 attributed to the presence of trypsin-or chymotrypsin-like activities (Godfrey, 1996) . Trypsin 241 and chymotrypsin are likely to be present within the porcine elastase preparation used in thisstudy as both enzymes together with elastase are secreted by the pancreas. Cleavage at the C 243 terminal side of Glu residues may arise from the presence of a Glu-specific exopeptidase or a 244 glutamyl endopeptidase-like activity. The degradation of proteolytic enzymes during the 245 course of hydrolysis may occur as a consequence of auto-digestion (Hema et al., 2017). The 246 presupposed presence of numerous enzyme activities within the elastase preparation herein 247 may suggest that auto-digestion of enzymes may have taken place over the course of the 248 hydrolytic reaction. However, this was not evaluated within this study. 249
There was a higher number of common peptides between βlgH-0.5 and βlgH-1, and βlgH-1 250 and βlgH-1.5 compared to βlgH-0.5 and βlgH-1.5, for both the DH9 and DH13 samples ( showed that βlg hydrolysates generated with trypsin at various pH values  7.8 displayed 256 major differences in peptide composition and also in the kinetics of peptide release. It has 257 been proposed that enzyme selectivity is a parameter which is more important than the DH to 258 define the characteristics of a hydrolysate. This is due to the fact that the kinetics of peptide 259 release may be influenced by factors such as charge (which is pH dependent), temperature, 260 enzyme active site conformation and its accessibility to the substrate (Butré, Sforza, Gruppen, A number of hypotheses are proposed to explain the differences in the peptides identified 265 within the βlgHs as follows: (i) when present within the folded protein, some peptide bonds 266 may not be accessible to the enzyme; (ii) when peptide bonds are located within a peptide as 267 opposed to in a protein, their accessibility to the enzyme may be increased; (iii) when the E:S 268 is low, the duration of accessibility for peptide bonds is longer and therefore the probability 269 of cleavage may be increased for peptide bonds for which the enzyme has a high specificity. 270
In addition, product type inhibition of the enzyme has been reported whereby peptides 271 released may compete with the protein substrate for binding at the active site of the enzyme, 272 resulting in slowing down kinetics of protein cleavage (Hema et al., 2017 ). An earlier study 273
showed that incubating porcine pancreatic elastase at 50C for 10 min did not alter its activity 274 whereas < 20% activity remained after exposure of elastase to 65C for 10 min (Ásgeirsson 275 & Bjarnason, 1993) . It is likely that following exposure to temperatures as high as 50C, 276 elastase may have been thermally denatured over longer incubation times of 20 to 50 min 277 used herein. 278
These differences in peptide bond accessibility and modulation of enzyme activity may 279 explain, for instance, why βlgH-1-DH9 had a substantial number of common peptides with 280 βlgH-0.5-DH9 and βlgH-1.5-DH9 whereas βlgH-0.5-DH9 and βlgH-1.5-DH9, which have a 281 greater E:S difference, had a lower number of common peptides (Fig. 3A) . As the kinetics of 282 cleavage of a peptide bond depend of its accessibility, this may explain why a longer 283 hydrolysis time with less enzyme may yield small differences in peptide profile compared to 284 a shorter hydrolysis time with a higher enzyme dose. It should also be noted that some 285 differences observed between the peptide sequences within samples may be attributed to 286 experimental limitations (i.e., solubility of the peptides during HILIC separation, poor 287 ionisation of the peptides in the ESI conditions employed) and the data treatment (i.e., poor 288 identification due to low detection intensity of peptides or poor MS fragmentation spectra). 289 Therefore, quantitation of the peptides released may be relevant in future studies, particularly 290 for samples produced under different hydrolysate manufacturing conditions. In addition, 291 other modes of separation (e.g., reverse phase or size exclusion chromatography) may be 292 used in future studies as this could yield additional peptide identification. 293
In silico digestion of βlg 294
Forty peptides ranging between 2 and 9 amino acids were predicted to be released in silico 295 following the digestion of βlg with elastase ( Table 2) . Features of DPP-IV inhibitory peptides 296 were found for 11 of the sequences obtained by the in silico prediction. The sequences 297 possessing the features of DPP-IV inhibitory peptides varied between 2-6 amino acids. 298
Among peptides predicted to be released in silico, 16 peptides (Table 2) Significant differences were found between in silico predictions and actual peptides released 307 as only one of the sequence predicted to be released (Glu-Glu-Gln-Cys-His-Ile) was actually 308 identified by LC-MS/MS within the βlgHs (Table 2) . However, several precursors of the 309 peptides predicted in silico were identified within the βlgHs (Supplementary Tables S1 and  310 S2). For example, in the case of the predicted peptide Leu-Ile-Val (βlg (f1-3)), larger 311 fragments ranging from βlg (f1-6) to βlg (f1-26) and βlg (f1-6) to βlg (f1-23) were identified 312 within the DH9 and DH13 βlgHs, respectively (Supplementary Tables S1 and S2) . 313
Discrepancies between the peptides predicted to be released and the actual peptides released 314 indicate that the hydrolysis of βlg was not complete. This was further supported by the 315 presence of large material > 10 kDa within all βlgHs ( Fig. 1) , which corresponded to 316 unhydrolysed βlg (molecular mass of 18.4 kDa) within these samples. In addition, the 317 estimated DH for complete digestion of βlg by elastase was 43.5%. This is higher than the 318 DH values (i.e., 9 and 13%) studied herein. 319
Previous studies have also reported on significant differences between in silico digestion of 320 individual proteins and actual peptide release during their in vitro enzymatic digestion. 
DPP-IV inhibitory activity of βlgH samples 337
As expected, the DPP-IV IC 50 values of all the βlgH samples were lower than that of the βlg-338 control (Table 1 Table S1 and S2) . 367
Conclusions

368
The strategy of decreasing the E:S while reaching the same DH by increasing the hydrolysis 369 time for βlg was validated for the generation of bioactive (i.e., DPP-IV inhibitory) 370 hydrolysates under the conditions studied herein. Even if samples with different E:S but 371 similar DH could be considered as comparable (molecular mass distribution and DPP-IV IC 50 372 values), some differences were observed at molecular level (i.e., peptides identified). These 373 differences may be attributed to variations in enzyme kinetics, selectivity and activity which 374 may depend on the enzyme concentration employed. In addition, while no modifications of 375 the DPP-IV inhibitory activity of βlgHs having the same DH were seen, this might not be the 376 case for other bioactive properties or other enzyme-substrate combinations. That is why it 377 would be of interest to quantify differences in peptides generated under different reaction 378
conditions. Further studies are required to elucidate the exact role of enzyme concentration on 379 the kinetics of peptide release and on enzyme selectivity and activity. This could support 380 selection of the most appropriate parameter(s) that could dictate the optimal conditions to 381 generate bioactive peptides at least cost. 382 Table 3 . Sequences of known dipeptidyl peptidase IV (DPP-IV) inhibitory peptides identified 552 within the β-lactoglobulin hydrolysates (βlgH) generated at degrees of hydrolysis (DH) of 9 553 and 13% under enzyme-to-substrate ratio (E:S) of 0.5 (βlgH-0.5-DH9; βlgH-0.5-DH13), 1.0 554 (βlgH-1-DH9; βlgH-1-DH13) and 1.5% (βlgH-1.5-DH9; βlgH-1.5-DH13). Peptides were 555 analysed by hydrophilic interaction liquid chromatography mass spectrometry (HILIC-556 UPLC-MS/MS) and then sequenced using PEAKS software. The presence or absence of 557 sequences identified within a sample was represented by the signs (+) and (-) respectively. 558 hydrolysed βlg (βlgH) to a degree of hydrolysis (DH) of (A) 9 and (B) 13% under enzyme-to-577 substrate ratio (E:S) of 0.5 (blue), 1.0 (yellow) and 1.5% (w/w) (magenta). Peptides were 578 analysed by hydrophilic interaction liquid chromatography mass spectrometry (HILIC-579 UPLC-MS/MS) and then sequenced using PEAKS software. Identified peptides common to 580 several samples were represented at the intersection of these specific samples. 581 Table 1 . 
